CoChat

Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis

Open access
Hooijmans, Carlijn R., Hlavica, Martin, Schuler, Florian A. F., Good, Nicolas, Good, Andrin, Baumgartner, Lisa, Galeno, Gianluca, Schneider, Marc P., Jung, Tarzis, de Vries, Rob, Ineichen, Benjamin V. · 2019 · Scientific Reports
Cited by 72

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

An unmet but urgent medical need is the development of myelin repair promoting therapies for Multiple Sclerosis (MS). Many such therapies have been pre-clinically tested using different models of toxic demyelination such as cuprizone, ethidium bromide, or lysolecithin and some of the therapies already entered clinical trials. However, keeping track on all these possible new therapies and their efficacy has become difficult with the increasing number of studies. In this study, we aimed at summarizing the current evidence on such therapies through a systematic review and at providing an estimate of the effects of tested interventions by a meta-analysis. We show that 88 different therapies have been pre-clinically tested for remyelination. 25 of them (28%) entered clinical trials. Our meta-analysis also identifies 16 promising therapies which did not enter a clinical trial for MS so far, among them Pigment epithelium-derived factor, Plateled derived growth factor, and Tocopherol derivate TFA-12.We also show that failure in bench to bedside translation from certain therapies may in part be attributable to poor study quality. By addressing these problems, clinical translation might be smoother and possibly animal numbers could be reduced.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-018-35734-4

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 72

Metadata

Authors
Hooijmans, C. R., Hlavica, M., Schuler, F. A. F., Good, N., Good, A., Baumgartner, L., Galeno, G., Schneider, M. P., Jung, T., de Vries, R., & Ineichen, B. V.
Venue
Scientific Reports
Published
2019-01-29
Volume
9
Issue
1
Pages
822-822
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2912881402
Cited by
72
References
22
FWCI
1.89
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1038/s41598-018-35734-4
The paper
Hooijmans, C. R., Hlavica, M., Schuler, F. A. F., Good, N., Good, A., Baumgartner, L., Galeno, G., Schneider, M. P., Jung, T., de Vries, R., & Ineichen, B. V. (2019). Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis. Scientific Reports. https://doi.org/10.1038/s41598-018-35734-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.